Piramal Pharma Limited
No trades
Fundamentals and stats
Top segments and regional performance
Last year, the company generated 91.51 B INR, the most of which — 24.84 B INR — came from its top-performing segment, Other Commercial Manufacturing. The greatest contribution came from North America, which accounted for 32.94 B INR last year, with 33.50 B INR the year before.
By source
By country